Skip to main content
Top
Published in: Pediatric Nephrology 2/2010

01-02-2010 | Review

Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood

Authors: Federica Vanoni, Alberto Bettinelli, Franco Keller, Mario G. Bianchetti, Giacomo D. Simonetti

Published in: Pediatric Nephrology | Issue 2/2010

Login to get access

Abstract

Immunoglobulin (Ig)G antineutrophil cytoplasmic autoantibodies are causally associated with necrotizing vasculitides that are characterized immunopathologically by little or no deposition of immunoreactants, such as Wegener granulomatosis, microscopic polyangiitis, Churg–Strauss angiitis, "renal-limited" vasculitis and a number of drug-induced vasculitides. Clinical routine testing targets the antigens myeloperoxidase and proteinase 3. However, in all of the conditions mentioned, the renal histopathologic findings are indistinguishable. Churg–Strauss angiitis (characterized by necrotizing vasculitis, granulomatous inflammation and tissue eosinophilia), Wegener granulomatosis (characterized by necrotizing vasculitis and granulomatous inflammation) and microscopic polyangiitis (characterized by necrotizing vasculitis) often present with fever, weight loss and a multisystem involvement (ear, nose, throat, lung, eyes, peripheral nerve and heart). Fifty years ago these conditions were very often fatal within 6 months of diagnosis. The introduction of corticosteroids and cyclophosphamide has resulted in a dramatic clinical benefit. Patients who develop treatment-related morbidity can be switched from cyclophosphamide to azathioprine after achieving remission. In patients with less severe disease, methotrexate achieves remission with a success rate similar to that of cyclophosphamide. Plasma exchange, in association with immunosuppression, is likely to be a beneficial therapy for patients with severe kidney disease or pulmonary hemorrhage.
Literature
1.
go back to reference Brogan PA (2007) What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 22:1083–1094CrossRef Brogan PA (2007) What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 22:1083–1094CrossRef
2.
go back to reference Jennette JC, Falk RJ (2008) New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol 20:55–60CrossRef Jennette JC, Falk RJ (2008) New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol 20:55–60CrossRef
3.
go back to reference Pusey CD (2006) The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis. J Am Soc Nephrol 17:1221–1223CrossRef Pusey CD (2006) The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis. J Am Soc Nephrol 17:1221–1223CrossRef
4.
go back to reference Kallenberg CG, Stegeman CA, Heeringa P (2008) Autoantibodies vex the vasculature. Nat Med 14:1018–1019CrossRef Kallenberg CG, Stegeman CA, Heeringa P (2008) Autoantibodies vex the vasculature. Nat Med 14:1018–1019CrossRef
5.
go back to reference Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941CrossRef Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941CrossRef
6.
go back to reference Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A (1999) International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111:507–513CrossRef Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A (1999) International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111:507–513CrossRef
7.
go back to reference Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, McEvoy R, Pusey C, Pollock W, Trevisin M, Wiik A, Wong R, International Group for Consensus Statement on Testing, Reporting of Antineutrophil Cytoplasmic Antibodies (2003) Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 120:312–318CrossRef Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, McEvoy R, Pusey C, Pollock W, Trevisin M, Wiik A, Wong R, International Group for Consensus Statement on Testing, Reporting of Antineutrophil Cytoplasmic Antibodies (2003) Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 120:312–318CrossRef
8.
go back to reference Moosig F, Lamprecht P, Gross WL (2008) Wegener's granulomatosis: the current view. Clin Rev Allergy Immunol 35:19–21CrossRef Moosig F, Lamprecht P, Gross WL (2008) Wegener's granulomatosis: the current view. Clin Rev Allergy Immunol 35:19–21CrossRef
9.
go back to reference Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS (1993) Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122:26–31CrossRef Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, Hoffman GS (1993) Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr 122:26–31CrossRef
10.
go back to reference Laux-End R, Gerber HA, Sauvain MJ, Bianchetti MG (1997) Anti-neutrophil autoantibodies and systemic vasculitis: a report of five cases. Acta Paediatr 86:438–439CrossRef Laux-End R, Gerber HA, Sauvain MJ, Bianchetti MG (1997) Anti-neutrophil autoantibodies and systemic vasculitis: a report of five cases. Acta Paediatr 86:438–439CrossRef
11.
go back to reference Stegmayr BG, Gothefors L, Malmer B, Müller Wiefel DE, Nilsson K, Sundelin B (2000) Wegener granulomatosis in children and young adults. A case study of ten patients. Pediatr Nephrol 14:208–213CrossRef Stegmayr BG, Gothefors L, Malmer B, Müller Wiefel DE, Nilsson K, Sundelin B (2000) Wegener granulomatosis in children and young adults. A case study of ten patients. Pediatr Nephrol 14:208–213CrossRef
12.
go back to reference Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED (2007) Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum 57:837–844CrossRef Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED (2007) Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum 57:837–844CrossRef
13.
go back to reference Belostotsky VM, Shah V, Dillon MJ (2002) Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 17:754–761CrossRef Belostotsky VM, Shah V, Dillon MJ (2002) Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 17:754–761CrossRef
14.
go back to reference Jennette JC, Thomas DB, Falk RJ (2001) Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 18:3–13PubMed Jennette JC, Thomas DB, Falk RJ (2001) Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 18:3–13PubMed
15.
go back to reference Jayne D (2008) Challenges in the management of microscopic polyangiitis: past, present and future. Curr Opin Rheumatol 20:3–9CrossRef Jayne D (2008) Challenges in the management of microscopic polyangiitis: past, present and future. Curr Opin Rheumatol 20:3–9CrossRef
16.
go back to reference Besbas N, Ozen S, Saatci U, Topaloğlu R, Tinaztepe K, Bakkaloglu A (2000) Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish children. Pediatr Nephrol 14:325–327CrossRef Besbas N, Ozen S, Saatci U, Topaloğlu R, Tinaztepe K, Bakkaloglu A (2000) Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish children. Pediatr Nephrol 14:325–327CrossRef
17.
go back to reference von Vigier RO, Trummler SA, Laux-End R, Sauvain MJ, Truttmann AC, Bianchetti MG (2000) Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature. Pediatr Pulmonol 29:382–388CrossRef von Vigier RO, Trummler SA, Laux-End R, Sauvain MJ, Truttmann AC, Bianchetti MG (2000) Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature. Pediatr Pulmonol 29:382–388CrossRef
18.
go back to reference Langford CA, Balow JE (2003) New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney. Curr Opin Nephrol Hypertens 12:267–272CrossRef Langford CA, Balow JE (2003) New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney. Curr Opin Nephrol Hypertens 12:267–272CrossRef
19.
go back to reference Booth AD, Pusey CD, Jayne DR (2004) Renal vasculitis—an update in 2004. Nephrol Dial Transplant 19:1964–1968CrossRef Booth AD, Pusey CD, Jayne DR (2004) Renal vasculitis—an update in 2004. Nephrol Dial Transplant 19:1964–1968CrossRef
20.
go back to reference Hattori M, Kurayama H, Koitabashi Y, Japanese Society for Pediatric Nephrology (2001) Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 12:1493–1500PubMed Hattori M, Kurayama H, Koitabashi Y, Japanese Society for Pediatric Nephrology (2001) Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 12:1493–1500PubMed
21.
go back to reference Noth I, Strek ME, Leff AR (2003) Churg–Strauss syndrome. Lancet 361:587–594CrossRef Noth I, Strek ME, Leff AR (2003) Churg–Strauss syndrome. Lancet 361:587–594CrossRef
22.
go back to reference Grau RG (2008) Churg-Strauss syndrome: 2005–2008 update. Curr Rheumatol Rep 10:453–458CrossRef Grau RG (2008) Churg-Strauss syndrome: 2005–2008 update. Curr Rheumatol Rep 10:453–458CrossRef
23.
go back to reference Beasley R, Bibby S, Weatherall M (2008) Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander? Thorax 63:847–849CrossRef Beasley R, Bibby S, Weatherall M (2008) Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander? Thorax 63:847–849CrossRef
25.
26.
go back to reference Gao Y, Zhao MH (2009) Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14:33–41CrossRef Gao Y, Zhao MH (2009) Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton) 14:33–41CrossRef
27.
go back to reference Laux-End R, Inaebnit D, Gerber HA, Bianchetti MG (1996) Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 75:355–356CrossRef Laux-End R, Inaebnit D, Gerber HA, Bianchetti MG (1996) Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 75:355–356CrossRef
28.
go back to reference Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL (2003) Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63:1079–1085CrossRef Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL (2003) Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63:1079–1085CrossRef
29.
go back to reference Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007) Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 298:655–669CrossRef Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007) Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 298:655–669CrossRef
30.
go back to reference Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310–317CrossRef Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310–317CrossRef
31.
go back to reference Lee RW, D'Cruz DP (2008) Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Drugs 68:747–770CrossRef Lee RW, D'Cruz DP (2008) Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Drugs 68:747–770CrossRef
32.
go back to reference Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD, European Vasculitis Study Group (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188CrossRef Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD, European Vasculitis Study Group (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188CrossRef
33.
go back to reference Walsh M, Jayne D (2009) Targeting the B cell in vasculitis. Pediatr Nephrol 24:1267–1275CrossRef Walsh M, Jayne D (2009) Targeting the B cell in vasculitis. Pediatr Nephrol 24:1267–1275CrossRef
34.
go back to reference Simonetti GD, Santoro L, Ferrarini A, Crosazzo-Franscini L, Fossali E, Bianchetti MG, CHILD Project (2007) Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. Paediatr Drugs 9:413–418CrossRef Simonetti GD, Santoro L, Ferrarini A, Crosazzo-Franscini L, Fossali E, Bianchetti MG, CHILD Project (2007) Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. Paediatr Drugs 9:413–418CrossRef
35.
go back to reference Hadtstein C, Schaefer F (2008) Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 23:363–371CrossRef Hadtstein C, Schaefer F (2008) Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 23:363–371CrossRef
36.
go back to reference Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82:23–28CrossRef Quan A (2006) Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82:23–28CrossRef
Metadata
Title
Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood
Authors
Federica Vanoni
Alberto Bettinelli
Franco Keller
Mario G. Bianchetti
Giacomo D. Simonetti
Publication date
01-02-2010
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 2/2010
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-009-1253-3

Other articles of this Issue 2/2010

Pediatric Nephrology 2/2010 Go to the issue